Solid carriers for improved delivery of active ingredients in pharmaceutical compositions 机翻标题: 暂无翻译,请尝试点击翻译按钮。

公开号/公开日
US2015273067 A1 2015-10-01 [US20150273067] / 2015-10-01
申请号/申请日
2015US-14713692 / 2015-05-15
发明人
PATEL MAHESH V;
申请人
LIPOCINE;
主分类号
IPC分类号
A61K-009/02A61K-009/14A61K-009/16A61K-009/20A61K-009/22A61K-009/32A61K-009/48A61K-009/50A61K-009/51A61K-009/52A61K-009/54A61K-009/56A61K-009/58A61K-031/216A61K-031/232A61K-031/351A61K-031/366A61K-031/40A61K-031/404A61K-031/415A61K-031/4196A61K-031/421A61K-031/436A61K-031/4409A61K-031/4439A61K-031/4725A61K-031/522A61K-031/568A61K-031/57A61K-031/64A61K-031/663A61K-038/23A61K-047/02A61K-047/10A61K-047/14A61K-047/22A61K-047/26A61K-047/28A61K-047/32A61K-047/36A61K-047/38A61K-047/44A61P-001/04A61P-003/04A61P-003/06A61P-003/10A61P-005/16A61P-005/24A61P-005/40A61P-007/02A61P-007/10A61P-009/04A61P-009/06A61P-009/10A61P-009/12A61P-013/08A61P-015/10A61P-017/12A61P-019/06A61P-019/10A61P-021/02A61P-025/04A61P-025/06A61P-025/08A61P-025/16A61P-025/20A61P-025/22A61P-025/26A61P-025/28A61P-029/00A61P-031/04A61P-031/10A61P-031/12A61P-033/06A61P-033/10A61P-035/00A61P-037/06A61P-043/00
摘要
(US20150273067) The present invention provides solid pharmaceutical compositions for improved delivery of a wide variety of pharmaceutical active ingredients contained therein or separately administered.  In one embodiment, the solid pharmaceutical composition includes a solid carrier, the solid carrier including a substrate and an encapsulation coat on the substrate.  The encapsulation coat can include different combinations of pharmaceutical active ingredients, hydrophilic surfactant, lipophilic surfactants and triglycerides.  In another embodiment, the solid pharmaceutical composition includes a solid carrier, the solid carrier being formed of different combinations of pharmaceutical active ingredients, hydrophilic surfactants, lipophilic surfactants and triglycerides.  The compositions of the present invention can be used for improved delivery of hydrophilic or hydrophobic pharmaceutical active ingredients, such as drugs, nutritional agents, cosmeceuticals and diagnostic agents.
机翻摘要
暂无翻译结果,您可以尝试点击头部的翻译按钮。
地址
代理人
代理机构
;
优先权号
1999US-09447690 1999-11-23 2002US-10159601 2002-05-30 2005US-11196805 2005-08-02 2008US-12326711 2008-12-02 2014US-14460188 2014-08-14 2015US-14713692 2015-05-15
主权利要求
(US20150273067) What is claimed and desired to be secured by United States Letters Patent is: 21.  A pharmaceutical composition formulated for oral delivery, the composition comprising: (1) an active ingredient, which is testosterone undecanoate;   (2) a lipophilic surfactant, which is a mono- and/or di-glyceride;   (3) a non-ionic hydrophilic surfactant, which is polyoxyl 40 castor oil (CREMPOPHOR (Registered trademark)  RH40); and   (4) polyethylene glycol;   wherein the composition is free of ethanol. 1-20. (canceled) 22. The pharmaceutical composition of claim 21, wherein the mono- and/or di-glyceride is glycerol monolinoleate (Maisine).
法律状态
(US20150273067) LEGAL DETAILS FOR US2015273067  Actual or expected expiration date=2025-08-02    Legal state=ALIVE    Status=PENDING     Event publication date=2015-05-15  Event code=US/APP  Event indicator=Pos  Event type=Examination events  Application details  Application country=US US14713692  Application date=2015-05-15  Standardized application number=2015US-14713692     Event publication date=2015-06-22  Event code=US/AS  Event type=Change of name or address  Event type=Reassignment  Assignment OWNER: LIPOCINE INC., UTAH  Effective date of the event=2015-06-19  ASSIGNMENT OF ASSIGNORS INTEREST ASSIGNOR:PATEL, MAHESH V. REEL/FRAME:035873/0905     Event publication date=2015-10-01  Event code=US/A1  Event type=Examination events  Application published  Publication country=US  Publication number=US2015273067  Publication stage Code=A1  Publication date=2015-10-01  Standardized publication number=US20150273067
专利类型码
A1
国别省市代码
若您需要申请原文,请登录。

最新评论

暂无评论。

登录后可以发表评论

意见反馈
返回顶部